15-min delayed · Sep 9, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering ATS Corporation, 1 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $35.00 to $50.00, a moderate spread. The average target of $42.50 sits 120% above the current $19.36. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees revenue growth near 4% next year, consensus EPS building from about $0.30 next quarter toward $1.38 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Moderate Buy
Strong Buy00%
Buy150%
Hold150%
Sell00%
Strong Sell00%
Based on 2 analysts giving stock ratings to ATS Corporation.
As of Sep, 1 of 2 firms rate ATS a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
ATS EPS & revenue forecast
EPS · NEXT QUARTER
$0.30
Range $0.23 – $0.37 · 8 analysts · -16% YoY
Next period, 8 analysts expect ATS Corporation to earn $0.30 a share (range $0.23 – $0.37), versus $0.35 a year earlier. Full-year consensus is $1.09, growing to $1.38 the year after.
REVENUE · NEXT QUARTER
$730.5M
Range $701.5M – $758.7M · 8 analysts · +4% YoY
Revenue is expected to reach $730.5M (range $701.5M – $758.7M), +4.0% year-over-year. Full-year consensus is $2.9B, rising to $3.0B next year.
Top analysts covering ATS Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ATS.
#1
Sabahat Khan
RBC Capital · Rank #380
Buy
$50.00+158.3% to target
Overall win rate
32%
+ Follow
#2
JG
Jonathan Goldman
Scotiabank
Buy
$46.00+137.6% to target
Coverage
—
+ Follow
#3
Stephen Tusa
JP Morgan
Hold
$35.00+80.8% to target
Coverage
—
+ Follow
#4
JK
Justin Keywood
Stifel Nicolaus
Buy
$52.00+168.6% to target
Coverage
—
+ Follow
#5
Joe Ritchie
Goldman Sachs
Sell
$30.00+55.0% to target
Coverage
—
+ Follow
ATS stock forecast FAQ
What is ATS's average 12-month price target?+
The 2 analysts with a live target average $42.50 for ATS Corporation over the next 12 months, ranging from a $50.00 high to a $35.00 low.
Is ATS stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 2 analyst ratings, 1 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for ATS?+
The Street-high target is $50.00 (RBC Capital), and the Street-low is $35.00 (JP Morgan). The average of all 2 active targets is $42.50.
How many Wall Street analysts cover ATS?+
2 analysts have an active rating on ATS Corporation, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering ATS?+
Among analysts who currently cover ATS, Sabahat Khan of RBC Capital has the strongest overall Quantellect track record (Rank #380). Their current call is Buy with a $50.00 target.
What is ATS Corporation's projected EPS for next quarter?+
The consensus estimate is $0.30 per share (range $0.23 – $0.37) across 8 analysts. Full-year EPS is projected at $1.09, rising to $1.38 the following year.
How much revenue is ATS Corporation expected to report next quarter?+
Consensus revenue is $730.5M (range $701.5M – $758.7M). Full-year revenue is projected at $2.9B, growing to $3.0B next year.
Have analysts been upgrading or downgrading ATS lately?+
As of Sep, 1 of 2 firms rate ATS a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ATS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
